Vigil Neuroscience, Inc.
NASDAQ:VIGL
3.6 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 1.934 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.113 | 0.113 | 0.113 | 0.11 | 0.474 | 0.383 | 0.274 | 0.253 | 0.246 | 0.237 | 0 | 0.151 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.113 | -0.113 | 1.821 | -0.11 | -0.474 | -0.383 | -0.274 | -0.253 | -0.246 | -0.237 | 0 | -0.151 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.942 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 13.772 | 15.54 | 14.326 | 16.782 | 15.415 | 14.903 | 13.834 | 12.191 | 12.791 | 12.097 | 10.365 | 9.119 | 7.81 | 8.648 | 6.753 | 3.177 | 22.26 |
| General & Administrative Expenses
| 6.904 | 6.938 | 7.089 | 7.075 | 6.906 | 7.01 | 6.941 | 6.682 | 4.846 | 4.945 | 4.967 | 3.858 | 2.928 | 2.128 | 1.165 | 0.882 | 0.895 |
| Selling & Marketing Expenses
| 0 | -0.113 | -0.113 | -0.113 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.904 | 6.825 | 6.976 | 6.962 | 6.906 | 7.01 | 6.941 | 6.682 | 4.846 | 4.945 | 4.967 | 3.858 | 2.928 | 2.128 | 1.165 | 0.882 | 0.895 |
| Other Expenses
| 0 | -0.003 | -0.002 | 0.002 | -0.003 | -0.007 | -0.005 | -0.009 | -0.026 | -0.005 | -0.004 | -0.008 | -0.002 | -0.592 | -0.275 | -0.177 | -1.155 |
| Operating Expenses
| 20.676 | 22.365 | 21.302 | 23.744 | 22.321 | 21.913 | 20.775 | 18.873 | 17.637 | 17.042 | 15.332 | 12.977 | 10.738 | 10.776 | 7.918 | 4.059 | 23.155 |
| Operating Income
| -20.676 | -22.478 | -21.415 | -23.857 | -22.321 | -21.913 | -20.775 | -18.873 | -17.637 | -17.042 | -15.332 | -12.977 | -10.738 | -10.776 | -7.918 | -4.059 | -23.155 |
| Operating Income Ratio
| 0 | 0 | 0 | -12.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.418 | 1.251 | 1.475 | 1.683 | 1.826 | -0.007 | 0.98 | 0.417 | 0.137 | 0.027 | -0.002 | -0.008 | -0.002 | -0.592 | -0.275 | -0.177 | -1.155 |
| Income Before Tax
| -19.258 | -21.227 | -19.94 | -22.174 | -20.495 | -20.174 | -19.795 | -18.456 | -17.5 | -17.015 | -15.334 | -12.985 | -10.74 | -11.367 | -8.191 | -4.236 | -24.31 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -11.465 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.07 | 2.901 | -0.11 | -1.746 | -1.045 | -32.791 | -0.137 | -0.027 | 0.002 | -12.98 | 0.002 | 0.59 | 0.271 | 0.177 | 1.155 |
| Net Income
| -19.258 | -21.227 | -19.94 | -22.174 | -20.495 | -20.174 | -18.75 | 14.335 | -17.363 | -16.988 | -15.336 | -12.985 | -10.74 | -11.367 | -8.191 | -4.236 | -24.31 |
| Net Income Ratio
| 0 | 0 | 0 | -11.465 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.47 | -0.52 | -0.5 | -0.57 | -0.53 | -0.52 | -0.49 | 0.37 | -0.52 | -0.6 | -0.58 | -0.46 | -0.38 | -0.54 | -0.39 | -0.2 | -1.15 |
| EPS Diluted
| -0.47 | -0.52 | -0.5 | -0.57 | -0.53 | -0.52 | -0.49 | 0.37 | -0.52 | -0.6 | -0.58 | -0.46 | -0.38 | -0.54 | -0.39 | -0.2 | -1.15 |
| EBITDA
| -20.676 | -22.365 | -21.302 | -23.744 | -22.321 | -21.802 | -20.775 | -18.873 | -17.616 | -17.024 | -15.314 | -12.977 | -10.726 | -10.775 | -7.918 | -4.059 | -23.155 |
| EBITDA Ratio
| 0 | 0 | 0 | -12.277 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |